lusianthridin

11/23/2023 - "Lusianthridin ameliorates high fat diet-induced metabolic dysfunction-associated fatty liver disease via activation of FXR signaling pathway."

04/01/2023 - "Corrigendum to:Lusianthridin targeting of lung cancer stem cells via Src-STAT3 suppression: Volume and pages of the publication: (Volume 62, September 2019, 152932)."
09/01/2019 - "Finally, we demonstrated that after CSC-attenuation by lusianthridin, the lung cancer cells exhibited significantly higher susceptibility to chemotherapeutic drugs. "
09/01/2019 - "Importantly, we confirmed the CSC-targeted activity of lusianthridin in CSC-rich primary lung cancer cells. "
09/01/2019 - "Herein, we report that lusianthridin, a pure compound from Dendrobium venustum, dramatically suppressed CSCs in lung cancer cells as verified by several CSC phenotype assessments and CSC markers. "
09/01/2019 - "Lusianthridin targeting of lung cancer stem cells via Src-STAT3 suppression."

09/01/2019 - "These findings revealed a novel pharmacological action and the underlying mechanism of lusianthridin in negatively regulating CSC-like phenotypes and sensitizing resistant cancer cells to cemetery."
02/20/2021 - "Lusianthridin was reported to possess many biological properties such as anti-oxidant and anti-cancer activities. "

06/14/2021 - "Taken together, lusianthridin could be a potential agent to be used to prevent atherosclerosis in thalassemia patients."

08/01/2023 - "Lusianthridin Exerts Streptozotocin-Induced Gestational Diabetes Mellitus in Female Rats via Alteration of TLR4/MyD88/NF-κB Signaling Pathway."